⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18969629 | 0.97 | — | — | |
| SCHEMBL2400421 | 0.94 | — | — | |
| SCHEMBL18717715 | 0.90 | — | — | |
| SCHEMBL14946387 | 0.83 | — | — | |
| SCHEMBL19625802 | 0.75 | — | — | |
| SCHEMBL23344730 | 0.73 | — | — | |
| SCHEMBL10513859 | 0.73 | — | — | |
| SCHEMBL1847666 | 0.71 | — | — | |
| SCHEMBL15491810 | 0.71 | — | — | |
| SCHEMBL23344719 | 0.69 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 48 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102497888-B | Perfluoro compounds for use in imaging | KONINKLIJKE PHILIPS ELECTRONICS N.V. (NL) | 2014-10-29 | — | — | CN | claimed |
| EP-1037619-A2 | SELECTED C 10? PERFLUORINATED HYDROCARBONS FOR LIQUID VENTILATION AND ARTIFICIAL BLOOD | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 2000-09-27 | — | — | EP | claimed |
| WO-1999026604-A2 | SELECTED C10 PERFLUORINATED HYDROCARBONS FOR LIQUID VENTILATION AND ARTIFICIAL BLOOD | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1999-06-03 | — | — | WO | claimed |
| US-20230212139-A1 | 2-AZASPIRO[3.4]OCTANE DERIVATIVES AS M4 AGONISTS | NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, INC. | 2023-07-06 | — | — | US | disclosed |
| US-20230183217-A1 | INHIBITORS OF LRRK2 KINASE | HALIA THERAPEUTICS INC (US) | 2023-06-15 | — | — | US | disclosed |
| US-20230159527-A1 | COMPOUNDS AS BCL-2 INHIBITORS | FOCHON BIOSCIENCES, LTD. (CN) | 2023-05-25 | — | — | US | disclosed |
| US-11648254-B2 | Substituted pyrido[2,3-d]pyrimidines as inhibitors of Ras pathway signaling | KUMQUAT BIOSCIENCES INC. (US) | 2023-05-16 | — | — | US | disclosed |
| US-20230136194-A1 | TRIAZOLOPYRIDAZINE DERIVATIVE, PREPARATION METHOD THEREFOR, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF | Shanghai Simr Biotechnology Co., Ltd. (CN) | 2023-05-04 | — | — | US | disclosed |
| US-9770439-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-09-26 | — | — | US | disclosed |
| US-9770439-B2 | Hepatitis C virus inhibitors | BRISTOL-MYERS SQUIBB COMPANY (US) | 2017-09-26 | — | — | US | disclosed |
| US-20160243237-A1 | EMULSIONS OF PERFLUOROCARBONS | TENAX THERAPEUTICS, INC. (US) | 2016-08-25 | — | — | US | disclosed |
| US-20100144597-A1 | Novel combinatorial approaches to enhancing oxygen transport to tissues | VIRGINIA COMMONWEALTH UNIVERSITY | 2010-06-10 | — | — | US | disclosed |
| US-20100144861-A1 | Perfluorocarbon gel formulations | TENAX THERAPEUTICS, INC | 2010-06-10 | — | — | US | disclosed |
| WO-2010033187-A1 | DEEP IMMERSION FLOTATION THERAPY FOR BURN VICTIMS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2010-03-25 | — | — | WO | disclosed |
| WO-2010008594-A1 | METHOD OF TREATING TRAUMATIC BRAIN INJURY | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2010-01-21 | — | — | WO | disclosed |
| WO-2009102487-A2 | GAS BASED WOUND AND TISSUE THERAPEUTICS | OXYGEN BIOTHERAPEUTICS, INC. (US) | 2009-08-20 | — | — | WO | disclosed |
| US-20090202617-A1 | Gas based wound and tissue therapeutics | TENAX THERAPEUTICS, INC | 2009-08-13 | — | — | US | disclosed |
| US-6167887-B1 | PERFLUOROALKYL(S)-SUBSTITUTED PERFLUOROCYCLOHEXANE AND -PENTANE USED AS BIOLOGICAL GAS EXCHANGE MEDIUM IN LIQUID VENTILATION AND ARTIFICIAL BLOOD; PROPER VAPOR PRESSURE SO DOESN'T CAUSE HYPERINFLATED LUNG SYNDROME; PURE SINGLE ISOMER | SYNTHETIC BLOOD INTERNATIONAL, INC. | 2001-01-02 | — | — | US | disclosed |
| EP-1037619-A2 | SELECTED C 10? PERFLUORINATED HYDROCARBONS FOR LIQUID VENTILATION AND ARTIFICIAL BLOOD | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 2000-09-27 | — | — | EP | disclosed |
| WO-1999026604-A2 | SELECTED C10 PERFLUORINATED HYDROCARBONS FOR LIQUID VENTILATION AND ARTIFICIAL BLOOD | SYNTHETIC BLOOD INTERNATIONAL, INC. (US) | 1999-06-03 | — | — | WO | disclosed |